Echelon Biosciences
UEI: EDK8FFD24SC4
• CAGE: 46MB5
Overview
Parent Awardee
Company Description
Welcome to Echelon Biosciences. We strive to leverage our expertise in custom synthesis and assay development to keep scientists moving forward.
Name
Echelon Biosciences
Website
Headquarters
Salt Lake City, UT
United States
United States
Most Recent Award
March 3, 2022
Calculating
Federal contract and grant recipient
ECHELON BIOSCIENCES INC
(UEI EDK8FFD24SC4, CAGE 46MB5)
is headquartered in Salt Lake City UT.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in October 1997 and
federally registered in
October 2005.
Federal Award Analysis
Echelon Biosciences federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Year | Contracts | Subcontracts | Grants | Subgrants |
---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ECHELON BIOSCIENCES INC
UEI
EDK8FFD24SC4
CAGE Code
46MB5
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Oct. 13, 1997
Initial Registration
Oct. 19, 2005
Last Registration
Feb. 26, 2024
Registration Activation
Feb. 26, 2024
Registration Expiration
Feb. 20, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
UT
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Echelon Biosciences
Contract Awards
Echelon Biosciences prime contract awards
Grant Awards
Echelon Biosciences direct grants
Subgrant Awards
Echelon Biosciences subgrant awards
Approved Supplier
CAGE 46MB5 Defense Logistics Agency approved NSNs
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Echelon Biosciences